These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35057621)

  • 1. A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
    Zahoránszky-Kőhalmi G; Siramshetty VB; Kumar P; Gurumurthy M; Grillo B; Mathew B; Metaxatos D; Backus M; Mierzwa T; Simon R; Grishagin I; Brovold L; Mathé EA; Hall MD; Michael SG; Godfrey AG; Mestres J; Jensen LJ; Oprea TI
    J Chem Inf Model; 2022 Feb; 62(3):718-729. PubMed ID: 35057621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
    Zahoránszky-Kőhalmi G; Siramshetty VB; Kumar P; Gurumurthy M; Grillo B; Mathew B; Metaxatos D; Backus M; Mierzwa T; Simon R; Grishagin I; Brovold L; Mathé EA; Hall MD; Michael SG; Godfrey AG; Mestres J; Jensen LJ; Oprea TI
    bioRxiv; 2020 Nov; ():. PubMed ID: 33173863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
    Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
    J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
    Sadegh S; Matschinske J; Blumenthal DB; Galindez G; Kacprowski T; List M; Nasirigerdeh R; Oubounyt M; Pichlmair A; Rose TD; Salgado-Albarrán M; Späth J; Stukalov A; Wenke NK; Yuan K; Pauling JK; Baumbach J
    Nat Commun; 2020 Jul; 11(1):3518. PubMed ID: 32665542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
    Ackerman EE; Shoemaker JE
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
    Fiscon G; Conte F; Farina L; Paci P
    PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
    Al-Saleem J; Granet R; Ramakrishnan S; Ciancetta NA; Saveson C; Gessner C; Zhou Q
    J Chem Inf Model; 2021 Aug; 61(8):4058-4067. PubMed ID: 34297570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.
    Hartman D; Kern S; Brown F; Minton SK; Rayner CR
    Clin Transl Sci; 2020 Jul; 13(4):646-648. PubMed ID: 32441462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Lima WG; Brito JCM; Overhage J; Nizer WSDC
    Arch Virol; 2020 Aug; 165(8):1729-1737. PubMed ID: 32514689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web tools to fight pandemics: the COVID-19 experience.
    Mercatelli D; Holding AN; Giorgi FM
    Brief Bioinform; 2021 Mar; 22(2):690-700. PubMed ID: 33057582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repositioning of COVID-19 based on mixed graph network and ion channel.
    Wang X; Li Q; Liu Y; Du Z; Jin R
    Math Biosci Eng; 2022 Jan; 19(4):3269-3284. PubMed ID: 35341251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
    Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
    J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing for COVID-19: could vitamin C combined with glycyrrhizic acid be at play by the findings of Li et al.'s database-based network pharmacology analysis?
    Huang YX; Wang WX; Tang YP; Yue SJ
    Brief Bioinform; 2021 Mar; 22(2):1508-1510. PubMed ID: 33253353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
    Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
    BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
    Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2.
    Fan S; Xiao D; Wang Y; Liu L; Zhou X; Zhong W
    Future Med Chem; 2020 Sep; 12(17):1565-1578. PubMed ID: 32638628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning.
    Azmoodeh SK; Tsigelny IF; Kouznetsova VL
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):113. PubMed ID: 35468672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.
    Lo CC; Shakya M; Connor R; Davenport K; Flynn M; Gutiérrez AMY; Hu B; Li PE; Jackson EP; Xu Y; Chain PSG
    Bioinformatics; 2022 May; 38(10):2700-2704. PubMed ID: 35561186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics.
    Terracciano R; Preianò M; Fregola A; Pelaia C; Montalcini T; Savino R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.